NuVasive, Inc.

Informe acción NasdaqGS:NUVA

Capitalización de mercado: US$2.1b

NuVasive Dirección

Dirección controles de criterios 3/4

El CEO de NuVasive's es Chris Barry , nombrado en Nov 2018, tiene una permanencia de 4.83 años. compensación anual total es $8.08M, compuesta por 11.1% salario y 88.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.14% de las acciones de la empresa, por valor de $2.90M. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 5.6 años, respectivamente.

Información clave

Chris Barry

Chief Executive Officer (CEO)

US$8.1m

Compensación total

Porcentaje del salario del CEO11.1%
Permanencia del CEO4.8yrs
Participación del CEO0.1%
Permanencia media de la dirección3.7yrs
Promedio de permanencia en la Junta Directiva5.6yrs

Actualizaciones recientes de la dirección

Recent updates

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Apr 18
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

Jan 24
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Dec 31
NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Dec 05
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Nov 13
These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Sep 22
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Sep 01
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

NuVasive Likely Undervalued, But It's Hard To Find Catalysts

Aug 17

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Aug 11
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M

Aug 03

NuVasive: Industry Tailwinds More Than Fairly Priced

Jun 13

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jun 01
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

May 11
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Apr 20
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

Mar 30
At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

NuVasive's Turnaround Story Needs A Boost From Better Results

Mar 01

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Dec 28
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

Dec 02
Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Nov 11
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Oct 21
NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

Sep 29
Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

Aug 18
At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

NuVasive Still Getting No Love With COVID-19 And Competitive Worries

Aug 12

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Jul 27
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Jun 17
Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

May 30
Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

May 12
Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Mar 30
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Mar 09
Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

Feb 16
Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jan 26
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

NuVasive stock gains on study results of its X360 surgery approach

Jan 06

What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 05
What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Chris Barry en comparación con los beneficios de NuVasive?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2023n/an/a

US$28m

Mar 31 2023n/an/a

US$20m

Dec 31 2022US$8mUS$897k

US$40m

Sep 30 2022n/an/a

-US$20m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$8mUS$875k

-US$64m

Sep 30 2021n/an/a

-US$26m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

-US$50m

Dec 31 2020US$5mUS$735k

-US$37m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

US$61m

Dec 31 2019US$5mUS$800k

US$65m

Sep 30 2019n/an/a

US$48m

Jun 30 2019n/an/a

US$52m

Mar 31 2019n/an/a

US$49m

Dec 31 2018US$5mUS$92k

US$12m

Compensación vs. Mercado: La compensación total de Chris($USD8.08M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.57M).

Compensación vs. Ingresos: La compensación de Chris ha sido consistente con los resultados de la empresa en el último año.


CEO

Chris Barry (50 yo)

4.8yrs

Permanencia

US$8,077,095

Compensación

Mr. J. Christopher Barry, also known as Chris, serves as Chief Executive Officer and Director of NuVasive, Inc., since November 5, 2018. Mr. Barry served commercial and leadership roles at Covidien. He has...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
J. Barry
CEO & Director4.8yrsUS$8.08m0.14%
$ 2.9m
Matthew Harbaugh
Principal Accounting Officer3.7yrsUS$2.97m0.020%
$ 418.2k
Dale Wolf
Senior Vice President of Global Operations3.7yrsUS$1.48m0.017%
$ 355.5k
Nathaniel Sisitsky
Senior VP5.3yrsUS$1.54m0.042%
$ 869.2k
Michael Farrington
Senior Vice President of People & Cultureless than a yearUS$1.03m0.0059%
$ 123.8k
Ryan Donahoe
Senior VP & Chief Technology Officer2yrssin datossin datos
Juliet Cunningham
Vice President of Investor Relationsno datasin datossin datos
Sean Freeman
Senior Vice President of Strategy & Corporate Development3.8yrssin datossin datos
Lisa Pecora
Vice President & Head of Global Commercial Finance5.3yrssin datossin datos
Aviva McPherron
Senior Vice President of Information Technology1.7yrssin datossin datos
Tristan Ribar
Vice President5.3yrssin datossin datos

3.7yrs

Permanencia media

48yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NUVA se considera experimentado (3.7 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
J. Barry
CEO & Director4.8yrsUS$8.08m0.14%
$ 2.9m
John DeFord
Independent Director5.6yrsUS$260.01k0%
$ 0
Robert Friel
Independent Director7.6yrsUS$260.01k0%
$ 0
Vickie Capps
Independent Director8.3yrsUS$280.01k0.0038%
$ 79.4k
R. Huennekens
Independent Director4.9yrsUS$260.01k0.0026%
$ 54.0k
Daniel Wolterman
Independent Chair8.2yrsUS$405.01k0%
$ 0
Leslie Norwalk
Independent Director9.3yrsUS$270.01k0.0059%
$ 123.0k
Siddhartha Kadia
Independent Director2.6yrsUS$260.01k0.0071%
$ 148.7k
Amy Raimundo
Independent Director2.1yrsUS$260.01k0%
$ 0

5.6yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de NUVA se considera experimentada (5.6 años de antigüedad promedio).